| 0 (0%) | 01-14 09:37 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 7.49 | 1-year : | 8.18 |
| Resists | First : | 6.41 | Second : | 7 |
| Pivot price | 6.01  |
|||
| Supports | First : | 5.46 | Second : | 4.54 |
| MAs | MA(5) : | 5.8 |
MA(20) : | 6.07 |
| MA(100) : | 4.57 |
MA(250) : | 3.43 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 31.1 |
D(3) : | 27.9 |
| RSI | RSI(14): 50.9 |
|||
| 52-week | High : | 7 | Low : | 1.88 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SVRA ] has closed above bottom band by 42.4%. Bollinger Bands are 13.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.93 - 5.95 | 5.95 - 5.98 |
| Low: | 5.54 - 5.57 | 5.57 - 5.6 |
| Close: | 5.87 - 5.92 | 5.92 - 5.97 |
Mon, 12 Jan 2026
Lobbying Update: $30,000 of SAVARA INC. lobbying was just disclosed - Quiver Quantitative
Sun, 11 Jan 2026
With 37% stake, Savara Inc. (NASDAQ:SVRA) seems to have captured institutional investors' interest - Yahoo Finance UK
Sun, 11 Jan 2026
With 37% stake, Savara Inc. (NASDAQ:SVRA) seems to have captured institutional investors' interest - Yahoo Finance
Sun, 11 Jan 2026
Savara Inc. (NASDAQ:SVRA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Fri, 09 Jan 2026
Savara (SVRA): Advancing MOLBREEVI Toward Likely FDA Approval and Blockbuster Rare Disease Potential - TipRanks
Fri, 09 Jan 2026
The Bull Case For Savara (SVRA) Could Change Following Exclusive MOLBREEVI Distribution Deal With PANTHERx - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 203 (M) |
| Shares Float | 118 (M) |
| Held by Insiders | 2.4 (%) |
| Held by Institutions | 83.5 (%) |
| Shares Short | 20,190 (K) |
| Shares Short P.Month | 18,390 (K) |
| EPS | -0.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.44 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -39.7 % |
| Return on Equity (ttm) | -78.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.42 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -99 (M) |
| Levered Free Cash Flow | -55 (M) |
| PE Ratio | -11.17 |
| PEG Ratio | 0 |
| Price to Book value | 13.15 |
| Price to Sales | 0 |
| Price to Cash Flow | -12.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|